A global offer to cellular infection and response
Thanks to its cellular biology platform, Smaltis offers different study models on eukaryotic cells.
Understanding the interactions between cells and bacteria is a key point in the fight against infections. Cellular infection models can predict the interactions and behavior of bacteria with eukaryotic cells.
For example, infection models of polarized epithelial cells have been shown to be very effective and predictive of bacterial interactions with the mucosal barrier in vivo.
In addition, cellular models allow other explorations such as the analysis of cytotoxicity induced by compounds or microorganisms.
Smaltis has thus equipped itself with a cell culture laboratory allowing to work on different lines and to propose various services. In partnership with the mAbEXperts group, Smaltis offers a global service related to the study of cellular response.
Services and tested products
Various models are already available or are specifically designed to accompany the development of products acting against bacterial infections or to evaluate the cytotoxicity of a compound or a microorganism. These cellular models allow the assessment of the impact of anti-infectious molecules, biomolecules, bacterial strains, bacterial compounds, and phages, on:
– Interactions between pathogenic bacteria or bacterial substances (supernatant, vesicles…) and eukaryotic cells
– The direct response of cells to these compounds or microorganisms
These pre-clinical services allow us to accompany you in your research projects and to provide data on your compounds or bacteria under development, in order to prepare regulatory files and to guide you in the screening of candidates.
Different prerequisites are necessary before any manipulation in order to correctly establish the experimental conditions:
- Determination of the optimal physiological conditions
- Minimum Inhibitory Concentration (MIC)
- Lethal Concentration 50 (LC50)
- Effective Concentration 50 (EC50)
- Multiplicity of Infection (MoI)
- Bacterial adhesion, aggregation and invasion: characterization and quantification
- Cytotoxicity: quantification of cell death by measuring the release of lactate dehydrogenase (LDH) into the medium, by assessing MTT cleavage, or by determining hemolytic activity (red blood cells lysis)
- Genomic response: quantification of specific gene expression to identify signaling pathways (e.g. inflammation, autophagy, apoptosis) by RT-qPCR
- Proteomic response: measurement of protein secretion (ELISA, ELIspot, Western Blot) in the culture medium after infection (e.g. cytokines/inflammatory mediators)
- Global cell response: migration (factor mediated), proliferation (evaluation of stimulation and growth by counting)
- Immunostaining with specific antibodies and visualization of fluorescence
- Bacterial enumeration
- ADCC: antibody-dependent cell-mediated cytotoxicity
- Stimulation of cytokine production by cells
- Phagocytosis of cells and bacteria
- ADCP: antibody-dependent phagocytosis
- Multiparametric analysis using Luminex™ technology
Sourcing of bacteria
- Intestinal cells
Caco2, T84, HT29
- Lung cells
A549 et NCI-H820
Murine macrophages J774A.1, THP-1 Monocytes
- Skin cells
- Other on request
- Tumor library: access to tumor cell lines or tissues from patients
- Reference strains
Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Escherichia coli, Enterobacter spp….
- Clinical strains
Access to more than 40 000 strains isolated from different pathologies
- Characterized mutant strains
Example: targeted mechanisms of resistance
Already available or to be created according to the project
- Patient’s samplings
Patient’s samplings containing bacterial strains
Examples of achievements
Immunostaining characterization of adhesion/invasion properties of E. coli strains on an intestinal cell line
Assessment of the effect of infant food compounds on the adhesion of E. coli strains to intestinal cells
Assessment of adhesion/invasion power of environmental strains (Pantoea sp, Arthobacter sp, Bacillus subtilis)
Characterization and assessment of cytotoxicity of mutants derived from P. aeruginosa strain PAO1 on lung lines and macrophages
Assessment of the effect of compounds and strains on extracellular and intracellular bacterial clearance
Assessment of the efficacy of antibacterial compounds on S. aureus strains phagocyted by macrophages
Determination of bacteriophages-induced cytotoxicity on osteoblasts line